Estimation of the neuraminidase content of influenza viruses and split-product vaccines by immunochromatography (Q81866414)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964668%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

title

Estimation of the neuraminidase content of influenza viruses and split-product vaccines by immunochromatography (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964668%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

Takeshi Tanimoto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964668%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Ritsuko Nakatsu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964668%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Isao Fuke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964668%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Toyokazu Ishikawa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964668%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Masahide Ishibashi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964668%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Kouichi Yamanishi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964668%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Michiaki Takahashi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964668%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Shin-ichi Tamura

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964668%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

publication date

1 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964668%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964668%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964668%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964668%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

4598-4609

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964668%20AND%20SRC:MED&resulttype=core&format=json

Association of serum anti-neuraminidase antibody with resistance to influenza in man.

13 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

Comparative efficacy of neuraminidase-specific and conventional influenza virus vaccines in induction of antibody to neuraminidase in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

Comparative long-term effects in a mouse model system of influenza whole virus and purified neuraminidase vaccines followed by sequential infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

Protection against influenza B virus infection by immunization with DNA vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

Antibody responses and protection against influenza virus infection in different congenic strains of mice immunized intranasally with adjuvant-combined A/Beijing/262/95 (H1N1) virus hemagglutinin or neuraminidase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

Effect of Ca++ on the stability of influenza virus neuraminidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

A molecular mechanism for the low‐pH stability of sialidase activity of influenza A virus N2 neuraminidases1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

A sensitive and specific ELISA immunocapture assay for rapid quantitation of influenza A/H3N2 neuraminidase protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

Quantification of neuramidase (NA) protein content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

Simultaneous purification of influenza haemagglutinin and neuraminidase proteins by immunochromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

Efficient selection for high-expression transfectants with a novel eukaryotic vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

Gene transfer into muscle by electroporation in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

Recombinant neuraminidase vaccine protects against lethal influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

Permanent canine kidney (MDCK) cells for isolation and plaque assay of influenza B viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

Plaque assay and primary isolation of influenza a viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

Quantitative analysis of the protein composition of influenza A and B viruses using high resolution SDS polyacrylamide gels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.042

10.1016/J.VACCINE.2005.04.042

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15964668%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference